Comparison of Hepatectomy and Transcatheter Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Necessity for Prospective Randomized Trial
- 1 September 1992
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 16 (3) , 702-706
- https://doi.org/10.1002/hep.1840160314
Abstract
Transcatheter arterial chemoembolization is now widely used in cases of surgically unresectable hepatocellular carcinoma. However, it is unclear whether patients with surgically resectable hepatocellular carcinoma should always be treated with hepatectomy as opposed to transcatheter arterial chemoembolization. Sixty–six patients with hepatocellular carcinoma underwent hepatectomy, whereas 29 patients with more advanced hepatocellular carcinoma were treated with transcatheter arterial chemoembolization at our hospital from 1984 to 1990. All cases were associated with cirrhosis of Child class A or B. All of them underwent hepatectomy or transcatheter arterial chemoembolization for the first time. Their outcomes were determined on March 31, 1991. The backgrounds and survival curves for hepatectomy and transcatheter arterial chemoembolization were compared in both Child A and Child B patients. For both Child A and B patients, no significant difference was found between hepatectomy and transcatheter arterial chemoembolization with respect to age, sex, cause of underlying cirrhosis, liver function assessed by indocyanine green test and maximum diameter of the main tumor. The incidence of multiple hepatocellular carcinoma, more advanced hepatocellular carcinoma (TNM stage III or IV) or both was significantly higher in the transcatheter arterial chemoembolization group than in the hepatectomy group for both Child A and Child B patients. The survival curves of both the hepatectomy and the transcatheter arterial chemoembolization groups showed no significant difference for both Child A and Child B patients. A prospective study is therefore warranted to elucidate whether hepatectomy or transcatheter arterial chemoembolization is more effective for treating resectable hepatocellular carcinoma associated with cirrhosis. (Hepatology 1992;16:702-706.)Keywords
This publication has 12 references indexed in Scilit:
- Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patientsHepatology, 1991
- Clinical and radiologic assessments of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrenceCancer, 1989
- Surgery of small hepatocellular carcinoma. Analysis of 144 casesCancer, 1989
- Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinomaCancer Chemotherapy and Pharmacology, 1989
- Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and Risk FactorsCancer Chemotherapy and Pharmacology, 1989
- Personal Experience With 411 Hepatic ResectionsAnnals of Surgery, 1988
- Combined peripheral and central chemoembolization of liver tumors.Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE)Cancer, 1988
- A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin spongeCancer, 1987
- Clinical Features and Long-term PrognosisAnnals of Surgery, 1987
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985